PONS is one of the 12 companies chosen for a program by Mayo Clinic Platform.

Our mission at PONS is to optimize access to healthcare and improve the quality of life for all individuals, irrespective of their location, race, or income. We aim to ensure that no one loses their loved ones prematurely due to preventable diseases. To achieve this, we enhance the capabilities of widely available ultrasound devices by integrating them with cloud-connected artificial intelligence. This innovation addresses the common limitations of imaging that hinder early disease detection and preventive screening. Through software advancements, we unlock a new era of proactive, personalized care, enabling healthcare providers to deliver effective and timely diagnostics. PONS` device-agnostic, patented software and AI models to optimize ultrasound imaging quality, augment tissue contrast, and reduce signal noise while revealing anatomical and pathological features, structural delineations, and microenvironmental context that remain undetectable with conventional ultrasound systems. PONS` patented technology can implement digital contrast without needing chemical contrast injected into the patients, revailing the surrounding on the earliest stages, Our proprietary deep learning algorithms quantitatively analyze temporal variations in morphological and spatial parameters—including tissue geometry, volumetric dimensions, location, surrounding and positional dynamics—to generate AI-powered diagnostic risk assessment reports.